Who are we?
Raz Pharmaceutics Ltd was established at the beginning of 2010 as a subsidiary company of Raz Progress. The company comply with the standards and certificates of the Ministry of health, supervised by the district Pharmacist and is licensed to market medicines. The company employs a staff of 8 pharmacists and an administrative stuff and leans on Raz Progress for its marketing and logistic efforts.
The pharmacy serves the regional community of Lev Hasharon, and especially the customers of Raz Progress throughout the country.
Raz Pharmaceutics services make Raz progress a One Stop Shop that responds to its customers’ need for quick service and a full and varied pharmaceutical solution (especially for small to medium geriatric institutions).
Drugs Disributed by Raz Pharmaceutics Ltd, Israel
Xanthine. Theophylline ethylenediamine 24 mg / ml. AMP: 10 x 10 ml for I.V. inj. Total dose should not exceed 0.8 ml/kg (equal to 5.6 mg of Aminophylline/kg).
Dosage must be individual.,
based on both symptom. respon. &
improv. in pulm. funct. See lit.
Bronchial asthma ;Pulmon. affect.
with bronchial spastic components.
C/I: Hypersens.
Ac. MI, hypotens. states, lact.
Anticholinergic agent. Atropine Sulphate 1 mg/ml. AMP. (sol. for IM, IV inj.): 5×1ml. Pre-anesthet. med.: Adults: 0.3-0.6 mg by IV inj. immed. before the anesthes. induct. or by IM inj. 30-60 min. before the induc.
Child.: 0.02 mg/kg (max. dose 0.6 mg).
Tmt. of sinus bradycard.: 0.3 and 1.0 mg IV.
Antidote in poison. by organophosphorus:
Adult.: 2 mg (IM or IV, taking into account the sever. of the poison.) every 5-10 min., until the skin becomes red and dry, the pupils dilate and tachycard. appears.
Child.: The 0.02 mg/kg.
Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension.
Antidote in poisoning by organophosphorus.
C/I: Hypersens. Clos. ang. glauc., esophag. reflux, pyloric stenosis, GI obstruct., ulcerat. colit., prostat. hypertrophy, paralytic ileus, intest. atony.
Sympathomimetic. Ephedrine hydrochloride 50 mg/ml. Amp. 5/10/100 X 50 mg/ml
Adj. dosage depend. on the cardiovasc. and hemodyn. parameters. For guid. purposes only: adults and adolesc.: 5-25 mg I.V., admin. slowly. It is recomm. that the prod. be admin. in div. doses of 5-10 mg until the blood press. normalizes. Max. daily dose - 150 mg.
Can also be admin. S.C. or I.M. The dose is 25-50 mg (range 10-50 mg). If necess., a sec. dose of 50 mg may be admin. I.M., or 10-25 mg admin. I.V.
Childr.: recomm. dose is 3 mg/kg per day (750 microgram/kg per dose) or 100 mg/m² per day (25mg/m2 per dose) div. in 4-6 doses, admin. S.C. or I.V.
The bolus I.V. dose for hypotens. is 0.1-0.3 mg/kg.
When admin.IV, the inject. should be given slowly.
Prevent. and tmt of hypotens. from spinal or epid. anesth. and during gral. anesth., with or without reduct. in the heart rate, admin. for a surg. or obstet. proced.
C/I: * Hypersens.
* Hyperexcitab., pheochromocytoma, arterioscl. and aneurism.
* Combin. with phenylpropanolamine, phenylephrine, pseudoephedrine, methylphenidate (other indirect sympathomimetics).
Admin. of this drug to pts. who are undergoing or have undergone tmt. with MAO inhibib. within the last 2 weeks is contraindic. as the combin. may cause sev., possibly fatal, hypertens.
Thyroid Hormones. Levothyroxine Sodium 0.2 mg/ml. Sol. for IM inject./concentr. for sol for inf. 6X 0.2 mg/ ml
Myxdema coma:Doses vary depend. on the degree of hypothyroidism, subject’s age and indiv. toler. Daily admin. until the pt. is able to toler. an oral dose and is clin. stable. Initial loading dose of 500 micrograms on first day.
Maint. tmt. at a daily dose of 100 μg on average.
Replacement or supplem. ther. in congenital or acquired hypothyroidism of any etiology: Compl. hne. replacement ther. in adults requires 100 to 150 μg as a single daily dose, on average. To be establ. gradually and with caution: start with 25 μg /d, then incr. the daily dose by 25 μg at weekly intervals.
Once the dosage has been stable for a long enough period, repeat testing of thyroid hnes. levels. See full prescription info.
Myxedema coma/ Replacement or supplem. ther. in congenital or acquired hypothyroidism of any etiology
C/I: Hypersens. /Untreat. adrenal insuff.
Untreat. pituitary insuff./ Untreat. thyrotoxicosis.
Untreat. hypertension/ Acute MI
Acute myocarditis/ Acute pancarditis
Analgesic/Antipyretic.. Paracetamol 10 mg/ml. Bottle. Sol for inf. 1 X 100 ml
The 100 ml bottle is restricted to pts. weighing more than 33 kg. Dose depends excl. on the patient`s weight. The volume must not exceed the determined dose. If applicable, the desired volume must be diluted in a suitable sol. for inf. prior to admin. or a syringe driver must be used.
Short-term tmt. of mod. pain, especially following surgery. Short-term tmt. of fever, when admin. by IV. route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of admin. are not possible.
C/I:Hypersens. Sev.hepatocellular insufficiency.
Antiseptic. Chlorhexidine Digluconate 0.015% w/v, Cetrimide 0.15% w/v. SACHETS (sterile, autoclaved sol.): 25 ml,
100 ml. Swab affect. area with contents
or pour directly on affect. area.
Disinfect. and clean. traum,. surg. wounds
and burns.
